Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
cancer
5
×
life sciences
national blog main
boston top stories
clinical trials
indiana blog main
indiana top stories
national top stories
san francisco blog main
san francisco top stories
biotech
blueprint medicines
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
avapritinib
boston
drugs
eli lilly
europe blog main
europe top stories
genentech
merck
roche
What
drug
5
×
fda
5
×
cancer
medicine
approval
approved
blueprint
genetic
address
announced
approves
bio
carries
certain
chasing
companies
deadly
deciphera
deeper
designed
digital
disease
dna
eisai
epidemic
fatty
filing
fingerprint
flags
forms
frenzied
gi
going
growing
higher
incidence
known
latest
led
liver
Language
unset
Current search:
cancer
×
fda
×
drug
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues